Muscat – Non-communicable diseases (NCDs) account for 80% of deaths in Oman and impose an economic burden of approximately RO1bn annually, according to H E Dr Ahmed bin Salem al Mandhari, Undersecretary for Planning and Health Regulation in Ministry of Health.

Speaking at the release of the first phase of the National Survey for Non-Communicable Diseases on Sunday, H E Dr Mandhari highlighted the urgent need for data-driven public health strategies to address the growing impact of NCDs. “Oman records more than 6,500 new cases of diabetes each year, over 2,000 new cancer cases, and one in three individuals suffers from hypertension,” he said. He added that 66% of the population is classified as overweight or obese, emphasising the need for stronger prevention, early detection and treatment measures.

Oman Vision 2040 identifies healthcare as a key pillar of sustainable development. In line with this, the government has intensified efforts to combat NCDs through initiatives such as early screening for diabetes, hypertension and kidney diseases, as well as tobacco control policies and campaigns promoting physical activity and healthy eating.

“The national survey is a critical step in gathering accurate data to help policymakers and healthcare professionals design targeted interventions,” Dr Mandhari said.

Dr Jean Jabbour, WHO Representative in Oman, described the rising burden of NCDs as a major challenge to the healthcare system and national development. “The WHO STEPS survey methodology will be used to assess key risk factors, including tobacco use, physical inactivity, unhealthy diet, high blood pressure and obesity,” he said.

Findings from Oman’s 2017 STEPS survey showed that obesity rates had increased from 54% in 2008 to 67% in 2017. Additionally, 39% of the population was physically inactive. These trends, Dr Jabbour noted, underline the need for urgent action to encourage healthier lifestyles.

The first phase of the national survey, launched on December 29, 2024, focused on updating household lists for random sample selection. The second phase, starting in April and lasting three months, will collect data through health questionnaires and clinical measurements, including height, weight, blood pressure, and blood tests for sugar and cholesterol levels.

By providing accurate, up-to-date information, the survey will support evidence-based policies to reduce NCD-related deaths and illnesses, consolidating Oman’s efforts to strengthen public health and improve the well-being of its population.